Cargando…
Insulin-Mediated Activation of the L-Arginine Nitric Oxide Pathway in Man, and Its Impairment in Diabetes
AIMS/HYPOTHESIS: Impaired L-arginine transport has been reported in cardiovascular diseases, providing a possible mechanism for reduced nitric oxide (NO) production. Given that cardiovascular diseases are also associated with insulin resistance, and insulin is known to induce vasodilation via a NO-d...
Autores principales: | Rajapakse, Niwanthi W., Chong, Abigail L., Zhang, Wei-Zheng, Kaye, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642141/ https://www.ncbi.nlm.nih.gov/pubmed/23658699 http://dx.doi.org/10.1371/journal.pone.0061840 |
Ejemplares similares
-
Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects
por: Giam, Beverly, et al.
Publicado: (2016) -
Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice
por: Rajapakse, Niwanthi W., et al.
Publicado: (2015) -
The L-arginine/nitric oxide pathway--biological properties and therapeutic applications.
por: Neilly, P. J., et al.
Publicado: (1994) -
Impact of the L-arginine-Nitric Oxide Pathway and Oxidative Stress on the Pathogenesis of the Metabolic Syndrome
por: Assumpção, C.R, et al.
Publicado: (2008) -
The Role of Exercise on L-Arginine Nitric Oxide Pathway in Chronic Heart Failure
por: Mendes-Ribeiro, A.C, et al.
Publicado: (2009)